Literature DB >> 7254967

Increased cholesterol and decreased fluidity of red cell membranes (spur cell anemia) in progressive intrahepatic cholestasis.

W F Balistreri, M H Leslie, R A Cooper.   

Abstract

Progressive hemolytic anemia occurred in a 4 1/2-year-old girl with familial intrahepatic cholestasis; a peripheral smear contained bizarre spiculated "spur" red cells. Analysis of this patient's fresh red cells revealed a 59% increase in cholesterol content with a normal phospholipid content and therefore an increase in the cholesterol/phospholipid molar ratio to 1.35 (normal = 0.92). A similar abnormality of lipid composition was present in serum lipoproteins. The lipid abnormality in red cell membrane was associated with a decrease in membrane fluidity, as assessed by the fluorescence polarization of the hydrophobic probe 1,6-diphenyl-1,3,5-hexatriene. Following incubation with patient's plasma, normal cells acquired a spur-shaped morphology with an associated decrease in osmotic fragility and a 25% increase in cholesterol content. The patient's cells, during incubation with normal plasma, acquired morphologic features of spiculated spherocytes with an increase in osmotic fragility and a 21% decrease in cholesterol content. Chenodeoxycholate and lithocholate were present in markedly elevated concentrations in serum. These studies show that a process identical to spur cell anemia in alcoholic cirrhosis may accompany severe liver disease in children with intrahepatic cholestasis.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7254967

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  6 in total

Review 1.  Influence of Erythrocyte Membrane Stability in Atherosclerosis.

Authors:  Mario da Silva Garrote-Filho; Morun Bernardino-Neto; Nilson Penha-Silva
Journal:  Curr Atheroscler Rep       Date:  2017-04       Impact factor: 5.113

2.  Successful combination therapy--flunarizine, pentoxifylline, and cholestyramine--for spur cell anemia.

Authors:  K Aihara; H Azuma; Y Ikeda; M Akaike; M Abe; T Sugihara; T Matsumoto
Journal:  Int J Hematol       Date:  2001-04       Impact factor: 2.490

3.  Lithocholate glucuronide is a cholestatic agent.

Authors:  D G Oelberg; M V Chari; J M Little; E W Adcock; R Lester
Journal:  J Clin Invest       Date:  1984-06       Impact factor: 14.808

4.  Structural determinants of monohydroxylated bile acids to activate beta 1 subunit-containing BK channels.

Authors:  Anna N Bukiya; Jacob McMillan; Abby L Parrill; Alejandro M Dopico
Journal:  J Lipid Res       Date:  2008-07-23       Impact factor: 5.922

5.  LKB1 is required for hepatic bile acid transport and canalicular membrane integrity in mice.

Authors:  Angela Woods; Amanda J Heslegrave; Phillip J Muckett; Adam P Levene; Melanie Clements; Margaret Mobberley; Timothy A Ryder; Shadi Abu-Hayyeh; Catherine Williamson; Robert D Goldin; Alan Ashworth; Dominic J Withers; David Carling
Journal:  Biochem J       Date:  2011-02-15       Impact factor: 3.857

6.  Changes in GM1 ganglioside content and localization in cholestatic rat liver.

Authors:  Marie Jirkovská; Filip Majer; Jaroslava Smídová; Jan Stríteský; Gouse Mohiddin Shaik; Petr Dráber; Libor Vítek; Zdenek Marecek; Frantisek Smíd
Journal:  Glycoconj J       Date:  2007-02-27       Impact factor: 3.009

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.